BNT Brookfield Wealth Solutions Ltd

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, announced today that John A. Sedor, president of the Company, will present at the Goldman Sachs 28th Annual Global Healthcare Conference at The Ritz-Carlton Laguna Niguel in Dana Point, California. The presentation is scheduled for Thursday, June 14th at 11:40AM (Eastern Time). This presentation will be broadcast live over the Internet and may be accessed via the Company�s web site, www.bentleypharm.com. In addition, a replay of the presentation will be available on the web site, beginning three hours after the presentation time. The replay will be archived for 30 days. Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and generic pharmaceutical products. Bentley�s proprietary drug delivery technologies enhance the absorption of pharmaceutical compounds across various membranes. Bentley manufactures and markets a growing portfolio of generic and branded generic pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and central nervous system diseases through its subsidiaries -- Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar and Bentley Pharmaceuticals Ireland. Bentley also manufactures and markets active pharmaceutical ingredients through its subsidiary, Bentley API. Additional information regarding Bentley Pharmaceuticals may be obtained through Bentley�s web site at www.bentleypharm.com.